Get the Stockscreener App
7.18
1.41%
0.09
Annexon Inc stock is traded at $7.18, with a volume of 529.37K.
It is up +1.41% in the last 24 hours and up +14.31% over the past month.
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.
See More
Previous Close:
$7.09
Open:
$7.15
24h Volume:
529.37K
Relative Volume:
0.45
Market Cap:
$747.50M
Revenue:
-
Net Income/Loss:
$-134.24M
P/E Ratio:
-3.6263
EPS:
-1.98
Net Cash Flow:
$-121.34M
1W Performance:
-5.02%
1M Performance:
+14.31%
6M Performance:
+47.34%
1Y Performance:
+177.61%
1-Day Range:
$6.94
$7.21
1-Week Range:
$6.85
$7.62
52-Week Range:
$2.045
$8.40
Annexon Inc Stock (ANNX) Company Profile
Name
Annexon Inc
Sector
Industry
Phone
(650)-822-5500
Address
1400 SIERRA POINT PARKWAY, BRISBANE
Annexon Inc Stock (ANNX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-16-22 | Initiated | Jefferies | Buy |
| Sep-09-22 | Initiated | BTIG Research | Buy |
| Nov-30-21 | Initiated | H.C. Wainwright | Buy |
| Sep-23-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-26-21 | Initiated | Needham | Buy |
| Aug-18-20 | Initiated | BofA Securities | Buy |
| Aug-18-20 | Initiated | Cowen | Outperform |
| Aug-18-20 | Initiated | JP Morgan | Overweight |
View All
Annexon Inc Stock (ANNX) Latest News
JP Morgan Upgrades Annexon (ANNX) - MSN
Annexon shares positive on ARCHER trial data, analyst maintains Buy rating - Investing.com
Annexon Presents Phase 2 Vision Preservation Data with ANX007 in Dry AMD Patients with Less - The Bakersfield Californian
Annexon Presents Phase 2 Vision Preservation Data with - GlobeNewswire
We're Hopeful That Annexon (NASDAQ:ANNX) Will Use Its Cash Wisely - Yahoo Finance
Tracking Annexon's Progress On Therapies For Complement-mediated Diseases - RTTNews
Annexon EVP Ted Yednock sells $40,073 in stock - Investing.com
Annexon EVP Ted Yednock sells $40,073 in stock By Investing.com - Investing.com South Africa
Insider Selling: Annexon, Inc. (NASDAQ:ANNX) EVP Sells 5,408 Shares of Stock - MarketBeat
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Where are the Opportunities in (ANNX) - Stock Traders Daily
A better buy-in window may exist right now for Annexon Inc (ANNX) - SETE News
Annexon to Present New Phase 2 ARCHER Data for ANX007 in Dry AMD Patients with Less Advanced GA at the American Academy of Ophthalmology 2024 Meeting - The Manila Times
Annexon to Present New Phase 2 ARCHER Data for ANX007 in - GlobeNewswire
Annexon Inc (ANNX) stock: A year of ups and downs - US Post News
Annexon, Inc. (NASDAQ:ANNX) Given Average Rating of "Buy" by Brokerages - MarketBeat
Annexon, Inc. (NASDAQ:ANNX) Short Interest Update - MarketBeat
Annexon, Inc. (NASDAQ:ANNX) Sees Significant Growth in Short Interest - MarketBeat
Eli Lilly and Company (NYSE:LLY) & Annexon (NASDAQ:ANNX) Head to Head Survey - Defense World
A Bullish 2024 Outlook For Annexon Inc (NASDAQ: ANNX) Shares - Stocks Register
Annexon, Inc. (NASDAQ:ANNX) Shares Purchased by AQR Capital Management LLC - MarketBeat
Annexon, Inc. (NASDAQ:ANNX) Shares Acquired by Dimensional Fund Advisors LP - MarketBeat
Recent Insider Activity Could Benefit Annexon Inc (ANNX) - Knox Daily
Views of Wall Street’s Leading Experts on Annexon Inc - SETE News
Annexon (NASDAQ:ANNX) Shares Up 4.7%What's Next? - MarketBeat
Annexon Inc (NASDAQ: ANNX) Could Fell Another -130.26% - Stocks Register
Is Annexon Inc (ANNX) a opportunity to investors? - US Post News
Annexon Inc (ANNX) Stock: A Year of Decreases and Increases - The InvestChronicle
Susquehanna Fundamental Investments LLC Purchases 129,455 Shares of Annexon, Inc. (NASDAQ:ANNX) - Defense World
Annexon, Inc. (NASDAQ:ANNX) Shares Acquired by Susquehanna Fundamental Investments LLC - MarketBeat
Director William Carson Acquires 3,200 Shares of Annexon Inc (AN - GuruFocus.com
Annexon director Carson buys $19k in company stock By Investing.com - Investing.com Australia
Annexon director Carson buys $19k in company stock - Investing.com
Annexon (NASDAQ:ANNX) Shares Up 6.5% - Defense World
Annexon (NASDAQ:ANNX) Trading Up 6.5% - MarketBeat
Analyzing Annexon Inc (ANNX) After Recent Trading Activity - Knox Daily
Are Annexon Inc’shares a good deal? - US Post News
Annexon shares maintain Overweight rating from Wells Fargo By Investing.com - Investing.com Canada
Renaissance Technologies LLC Lowers Position in Annexon, Inc. (NASDAQ:ANNX) - Defense World
Renaissance Technologies LLC Sells 87,000 Shares of Annexon, Inc. (NASDAQ:ANNX) - MarketBeat
Market Momentum: Annexon Inc (ANNX) Registers a 0.33 Increase, Closing at 6.14 - The Dwinnex
There is no doubt that Annexon Inc (ANNX) ticks all the boxes. - SETE News
Susquehanna Portfolio Strategies LLC Decreases Stake in Annexon, Inc. (NASDAQ:ANNX) - Defense World
Susquehanna Portfolio Strategies LLC Sells 103,902 Shares of Annexon, Inc. (NASDAQ:ANNX) - MarketBeat
Point72 Asset Management L.P. Purchases 832,617 Shares of Annexon, Inc. (NASDAQ:ANNX) - MarketBeat
Point72 Europe London LLP Invests $1.15 Million in Annexon, Inc. (NASDAQ:ANNX) - MarketBeat
Are Smart Investors Making the Right Decision? Annexon Inc (ANNX) - SETE News
ANNX’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle
Metric Deep Dive: Understanding Annexon Inc (ANNX) Through its Ratios - The Dwinnex
How to interpret Annexon Inc (ANNX)’s stock chart patterns - US Post News
Mutual of America Capital Management LLC Buys New Stake in Annexon, Inc. (NASDAQ:ANNX) - Defense World
Annexon Inc Stock (ANNX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.75%
0.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):